Mira Pharmaceuticals (MIRA) Accounts Payables (2022 - 2025)

Mira Pharmaceuticals has reported Accounts Payables for 4 years, with the latest figure at $129203.0 in Q4 2025.

• Quarterly Accounts Payables fell 82.14% year-over-year to $129203.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $129203.0 (down 82.14% YoY) and the FY2025 annual result came in at $129203.0, down 82.14% from the prior year.
• Accounts Payables grew to $129203.0 in Q4 2025 per MIRA's latest filing, from $83926.0 in the prior quarter.
• Over five years, Accounts Payables peaked at $811738.0 in Q4 2022 and troughed at $83926.0 in Q3 2025.
• A 4-year average of $495789.1 and a median of $636261.0 in 2024 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2024 and 2025: Accounts Payables jumped 34.31% in 2024, then sank 87.89% in 2025.
• Over 4 years, Accounts Payables stood at $811738.0 in 2022, then slumped by 33.65% to $538564.0 in 2023, then jumped by 34.31% to $723349.0 in 2024, then tumbled by 82.14% to $129203.0 in 2025.
• According to Business Quant data, Accounts Payables over the past three periods registered $129203.0, $83926.0, and $298459.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.